These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7433403)

  • 1. Labetalol in inadequately controlled hypertensive patients. A twice-daily oral regimen.
    Douglas-Jones AP
    Practitioner; 1980 Aug; 224(1346):841-4. PubMed ID: 7433403
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antihypertensive effects of labetalol administered parenterally and orally].
    Nicolaescu V; Serban-Pârâu G; Ionescu P; Nuţă M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(5):405-12. PubMed ID: 6151227
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugs.
    Pearson RM; Havard CW
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):795-8. PubMed ID: 10953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the the combination labetalol plus chlorthalidone in essential arterial hypertension therapy.
    Rossi AG
    Clin Ther; 1981; 3(6):441-9. PubMed ID: 7260990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term high-dose labetalol on blood pressure in patients with severe hypertension resistant to previous therapy.
    Kristensen BO; la Cour Petersen E
    Postgrad Med J; 1980; 56 Suppl 2():57-9. PubMed ID: 7433344
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
    la Cour Petersen E; Kristensen BO
    Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.
    McNeil JJ; Anderson AE; Louis WJ; Morgan DJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):157S-161S. PubMed ID: 526397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
    Thompson FD; Joekes AM; Hussein MM
    Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic receptors.
    Milne BJ; Logan AG
    Can Med Assoc J; 1980 Nov; 123(10):1013-6. PubMed ID: 6256045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-ranging study of labetalol in moderate to moderately severe hypertension.
    Darmansjah I; Setiawati A; Prabowo P; Sukandar E; Parsoedi I; Ardaya ; Bahry B; Jusman J; Anggraeni E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):226-31. PubMed ID: 7620693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous labetalol in hypertensive patients given by fast and slow injection.
    Pearson RM; Havard CW
    Br J Clin Pharmacol; 1978 May; 5(5):401-5. PubMed ID: 350248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA; Brown JJ; Lever AF; Robertson AS; Robertson JI; Trust PM
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.
    Anavekar SN; Barter C; Adam WR; Doyle AE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S374-7. PubMed ID: 6184571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of labetalol on the response of arterial blood pressure to exercise in hypertensive patients].
    Wajngarten M; Antunes JE; Pereyra PL; Godoy M; Dauar D; Martinelli Filho M; Pereira Barretto AC; Pileggi F
    Arq Bras Cardiol; 1983 Jan; 40(1):65-7. PubMed ID: 6615264
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of labetalol in elderly and young hypertensive patients following single and multiple doses.
    Rocci ML; Vlasses PH; Cressman MD; Sirgo MA; Plachetka JR
    Pharmacotherapy; 1990; 10(2):92-9. PubMed ID: 2349138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
    Rossi A; Ziacchi V; Lomanto B
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):438-45. PubMed ID: 6754634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol in the difficult hypertensive patient in general practice.
    Harris C
    Curr Med Res Opin; 1978; 5(8):618-24. PubMed ID: 710176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Intravenous labetalol in severe hypertension.
    Rosei EA; Trust PM; Brown JJ; Lever AF; Robertson JI
    Lancet; 1975 Nov; 2(7944):1093-4. PubMed ID: 53581
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term therapy with labetalol in medium and high grade arterial hypertension].
    Danti G; Pomari S; Covi G; Pedrolli E; Zannini G; Mattioli M; Lechi A
    Clin Ter; 1980 Apr; 93(2):169-82. PubMed ID: 7449336
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of labetalol in the treatment of hypertensive crises].
    Semplicini A; Pessina AC; Rossi GP; Palatini P; Hlede M; Morandin F; Visonà A; Mazzucato A; Dal Palù C
    G Ital Cardiol; 1982; 12(5):355-8. PubMed ID: 7152187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.